Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial.

Saved in:
Bibliographic Details
Title: Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial.
Authors: Wadden TA; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Tronieri JS; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Sugimoto D; Cedar Crosse Research Center, Chicago, Illinois, USA., Lund MT; Novo Nordisk A/S, Søborg, Denmark., Auerbach P; Novo Nordisk A/S, Søborg, Denmark., Jensen C; Novo Nordisk A/S, Søborg, Denmark., Rubino D; Washington Center for Weight Management and Research, Arlington, Virginia, USA.
Source: Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2020 Mar; Vol. 28 (3), pp. 529-536.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101264860 Publication Model: Print Cited Medium: Internet ISSN: 1930-739X (Electronic) Linking ISSN: 19307381 NLM ISO Abbreviation: Obesity (Silver Spring) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1930-739X
DOI:10.1002/oby.22726